CHD7

Protein-coding gene in the species Homo sapiens
CHD7
Available structures
PDBOrtholog search: PDBe RCSB
List of PDB id codes

2CKC, 2V0E, 2V0F

Identifiers
AliasesCHD7, CRG, HH5, IS3, KAL5, chromodomain helicase DNA binding protein 7
External IDsOMIM: 608892 MGI: 2444748 HomoloGene: 19067 GeneCards: CHD7
Gene location (Human)
Chromosome 8 (human)
Chr.Chromosome 8 (human)[1]
Chromosome 8 (human)
Genomic location for CHD7
Genomic location for CHD7
Band8q12.2Start60,678,740 bp[1]
End60,868,028 bp[1]
Gene location (Mouse)
Chromosome 4 (mouse)
Chr.Chromosome 4 (mouse)[2]
Chromosome 4 (mouse)
Genomic location for CHD7
Genomic location for CHD7
Band4 A1|4 3.68 cMStart8,690,406 bp[2]
End8,867,659 bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • secondary oocyte

  • cerebellar vermis

  • sural nerve

  • inferior ganglion of vagus nerve

  • external globus pallidus

  • subthalamic nucleus

  • ventral tegmental area

  • embryo

  • cerebellar hemisphere

  • pylorus
Top expressed in
  • external carotid artery

  • internal carotid artery

  • secondary oocyte

  • cerebellar cortex

  • primitive streak

  • lens

  • cerebellar vermis

  • blood

  • hair follicle

  • renal corpuscle
More reference expression data
BioGPS
n/a
Gene ontology
Molecular function
  • nucleotide binding
  • DNA binding
  • helicase activity
  • chromatin binding
  • RNA polymerase II cis-regulatory region sequence-specific DNA binding
  • hydrolase activity, acting on acid anhydrides
  • protein binding
  • hydrolase activity
  • ATP binding
  • promoter-specific chromatin binding
Cellular component
  • nucleus
  • nucleoplasm
  • nucleolus
Biological process
  • skeletal system development
  • olfactory behavior
  • semicircular canal morphogenesis
  • regulation of transcription, DNA-templated
  • cognition
  • locomotory behavior
  • adult heart development
  • cranial nerve development
  • heart morphogenesis
  • olfactory nerve development
  • in utero embryonic development
  • sensory perception of sound
  • blood circulation
  • transcription, DNA-templated
  • epithelium development
  • genitalia development
  • limb development
  • ear morphogenesis
  • regulation of growth hormone secretion
  • central nervous system development
  • T cell differentiation
  • face development
  • blood vessel development
  • retina development in camera-type eye
  • inner ear morphogenesis
  • artery morphogenesis
  • positive regulation of multicellular organism growth
  • rRNA processing
  • camera-type eye development
  • olfactory bulb development
  • nose development
  • female genitalia development
  • regulation of neurogenesis
  • adult walking behavior
  • embryonic hindlimb morphogenesis
  • ventricular trabecula myocardium morphogenesis
  • tissue remodeling
  • aorta morphogenesis
  • positive regulation of transcription by RNA polymerase II
  • right ventricular compact myocardium morphogenesis
  • regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
  • aorta development
  • atrioventricular canal development
  • blood vessel remodeling
  • chromatin remodeling
  • cardiac septum morphogenesis
  • innervation
  • chromatin organization
  • roof of mouth development
  • secondary palate development
  • response to bacterium
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

55636

320790

Ensembl

ENSG00000171316

ENSMUSG00000041235

UniProt

Q9P2D1

A2AJK6

RefSeq (mRNA)

NM_017780
NM_001316690
NM_017783

NM_001033395
NM_001081417
NM_001277149
NM_001355382

RefSeq (protein)

NP_001303619
NP_060250

NP_001264078
NP_001342311

Location (UCSC)Chr 8: 60.68 – 60.87 MbChr 4: 8.69 – 8.87 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Chromodomain-helicase-DNA-binding protein 7 is an ATP-dependent 'chromatin' or 'nucleosome' remodeling factor [5] that in humans is encoded by the CHD7 gene.[6][7]

CHD7 is an ATP-dependent chromatin remodeler homologous to the Drosophila trithorax-group protein Kismet.[8] Mutations in CHD7 are associated with CHARGE syndrome.[9] This protein belongs to a larger group of ATP-dependent chromatin remodeling complexes, the CHD subfamily.

Clinical

Mutations in this gene have been associated with the CHARGE syndrome.

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000171316 - Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000041235 - Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Bouazoune, K; Kingston, RE (20 November 2012). "Chromatin remodeling by the CHD7 protein is impaired by mutations that cause human developmental disorders". Proceedings of the National Academy of Sciences of the United States of America. 109 (47): 19238–43. Bibcode:2012PNAS..10919238B. doi:10.1073/pnas.1213825109. PMC 3511097. PMID 23134727.
  6. ^ Nagase T, Kikuno R, Ishikawa KI, Hirosawa M, Ohara O (Feb 2000). "Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro". DNA Research. 7 (1): 65–73. doi:10.1093/dnares/7.1.65. PMID 10718198.
  7. ^ "Entrez Gene: chromodomain helicase DNA binding protein 7".
  8. ^ Bajpai R, Chen DA, Rada-Iglesias A, Zhang J, Xiong Y, Helms J, Chang CP, Zhao Y, Swigut T, Wysocka J (Feb 2010). "CHD7 cooperates with PBAF to control multipotent neural crest formation". Nature. 463 (7283): 958–62. Bibcode:2010Natur.463..958B. doi:10.1038/nature08733. PMC 2890258. PMID 20130577.
  9. ^ Vissers LE, van Ravenswaaij CM, Admiraal R, Hurst JA, de Vries BB, Janssen IM, van der Vliet WA, Huys EH, de Jong PJ, Hamel BC, Schoenmakers EF, Brunner HG, Veltman JA, van Kessel AG (Sep 2004). "Mutations in a new member of the chromodomain gene family cause CHARGE syndrome". Nature Genetics. 36 (9): 955–7. doi:10.1038/ng1407. PMID 15300250.

Further reading

  • Delahaye A, Sznajer Y, Lyonnet S, Elmaleh-Bergès M, Delpierre I, Audollent S, Wiener-Vacher S, Mansbach AL, Amiel J, Baumann C, Bremond-Gignac D, Attié-Bitach T, Verloes A, Sanlaville D (Aug 2007). "Familial CHARGE syndrome because of CHD7 mutation: clinical intra- and interfamilial variability". Clinical Genetics. 72 (2): 112–21. doi:10.1111/j.1399-0004.2007.00821.x. PMID 17661815. S2CID 8143298.
  • Van de Laar I, Dooijes D, Hoefsloot L, Simon M, Hoogeboom J, Devriendt K (Nov 2007). "Limb anomalies in patients with CHARGE syndrome: an expansion of the phenotype". American Journal of Medical Genetics Part A. 143A (22): 2712–5. doi:10.1002/ajmg.a.32008. PMID 17937444. S2CID 21353716.
  • Holak HM, Kohlhase J, Holak SA, Holak NH (Jun 2008). "New recognized ophthalmic morphologic anomalies in CHARGE syndrome caused by the R2319C mutation in the CHD7 gene". Ophthalmic Genetics. 29 (2): 79–84. doi:10.1080/13816810801918391. PMID 18484313. S2CID 205807551.
  • Sanlaville D, Verloes A (Apr 2007). "CHARGE syndrome: an update". European Journal of Human Genetics. 15 (4): 389–99. doi:10.1038/sj.ejhg.5201778. PMID 17299439.
  • Kim HG, Kurth I, Lan F, Meliciani I, Wenzel W, Eom SH, Kang GB, Rosenberger G, Tekin M, Ozata M, Bick DP, Sherins RJ, Walker SL, Shi Y, Gusella JF, Layman LC (Oct 2008). "Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome". American Journal of Human Genetics. 83 (4): 511–9. doi:10.1016/j.ajhg.2008.09.005. PMC 2561938. PMID 18834967.
  • Dagle JM, Lepp NT, Cooper ME, Schaa KL, Kelsey KJ, Orr KL, Caprau D, Zimmerman CR, Steffen KM, Johnson KJ, Marazita ML, Murray JC (Apr 2009). "Determination of genetic predisposition to patent ductus arteriosus in preterm infants". Pediatrics. 123 (4): 1116–23. doi:10.1542/peds.2008-0313. PMC 2734952. PMID 19336370.
  • Wincent J, Schulze A, Schoumans J (2009). "Detection of CHD7 deletions by MLPA in CHARGE syndrome patients with a less typical phenotype". European Journal of Medical Genetics. 52 (4): 271–2. doi:10.1016/j.ejmg.2009.02.005. PMID 19248844.
  • Wincent J, Holmberg E, Strömland K, Soller M, Mirzaei L, Djureinovic T, Robinson K, Anderlid B, Schoumans J (Jul 2008). "CHD7 mutation spectrum in 28 Swedish patients diagnosed with CHARGE syndrome". Clinical Genetics. 74 (1): 31–8. doi:10.1111/j.1399-0004.2008.01014.x. PMID 18445044. S2CID 205406725.
  • Gennery AR, Slatter MA, Rice J, Hoefsloot LH, Barge D, McLean-Tooke A, Montgomery T, Goodship JA, Burt AD, Flood TJ, Abinun M, Cant AJ, Johnson D (Jul 2008). "Mutations in CHD7 in patients with CHARGE syndrome cause T-B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome". Clinical and Experimental Immunology. 153 (1): 75–80. doi:10.1111/j.1365-2249.2008.03681.x. PMC 2432100. PMID 18505430.
  • Tellier AL, Cormier-Daire V, Abadie V, Amiel J, Sigaudy S, Bonnet D, de Lonlay-Debeney P, Morrisseau-Durand MP, Hubert P, Michel JL, Jan D, Dollfus H, Baumann C, Labrune P, Lacombe D, Philip N, LeMerrer M, Briard ML, Munnich A, Lyonnet S (Apr 1998). "CHARGE syndrome: report of 47 cases and review". American Journal of Medical Genetics. 76 (5): 402–9. doi:10.1002/(SICI)1096-8628(19980413)76:5<402::AID-AJMG7>3.0.CO;2-O. PMID 9556299.
  • Jongmans MC, van Ravenswaaij-Arts CM, Pitteloud N, Ogata T, Sato N, Claahsen-van der Grinten HL, van der Donk K, Seminara S, Bergman JE, Brunner HG, Crowley WF, Hoefsloot LH (Jan 2009). "CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome". Clinical Genetics. 75 (1): 65–71. doi:10.1111/j.1399-0004.2008.01107.x. PMC 2854009. PMID 19021638.
  • Jongmans MC, Hoefsloot LH, van der Donk KP, Admiraal RJ, Magee A, van de Laar I, Hendriks Y, Verheij JB, Walpole I, Brunner HG, van Ravenswaaij CM (Jan 2008). "Familial CHARGE syndrome and the CHD7 gene: a recurrent missense mutation, intrafamilial recurrence and variability". American Journal of Medical Genetics Part A. 146A (1): 43–50. doi:10.1002/ajmg.a.31921. PMID 18074359. S2CID 24479591.
  • Vuorela PE, Penttinen MT, Hietala MH, Laine JO, Huoponen KA, Kääriäinen HA (Oct 2008). "A familial CHARGE syndrome with a CHD7 nonsense mutation and new clinical features". Clinical Dysmorphology. 17 (4): 249–53. doi:10.1097/MCD.0b013e328306a704. PMID 18978652. S2CID 35257043.
  • Bergman JE, de Wijs I, Jongmans MC, Admiraal RJ, Hoefsloot LH, van Ravenswaaij-Arts CM (2008). "Exon copy number alterations of the CHD7 gene are not a major cause of CHARGE and CHARGE-like syndrome". European Journal of Medical Genetics. 51 (5): 417–25. doi:10.1016/j.ejmg.2008.03.003. PMID 18472328.
  • Lee YW, Kim SC, Shin YL, Kim JW, Hong HS, Lee YK, Ki CS (Mar 2009). "Clinical and genetic analysis of the CHD7 gene in Korean patients with CHARGE syndrome". Clinical Genetics. 75 (3): 290–3. doi:10.1111/j.1399-0004.2008.01127.x. PMID 19159393. S2CID 43480931.
  • Qi Q, Yi L, Yang C, Chen H, Shen L, Mo X, Hu Y, Wang Y (Dec 2008). "[Mutation analysis of the CHD7 gene in patients with congenital heart disease]". Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics. 25 (6): 637–41. PMID 19065520.
  • Writzl K, Cale CM, Pierce CM, Wilson LC, Hennekam RC (2007). "Immunological abnormalities in CHARGE syndrome". European Journal of Medical Genetics. 50 (5): 338–45. doi:10.1016/j.ejmg.2007.05.002. PMID 17684005.
  • Nakajima D, Okazaki N, Yamakawa H, Kikuno R, Ohara O, Nagase T (Jun 2002). "Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones". DNA Research. 9 (3): 99–106. doi:10.1093/dnares/9.3.99. PMID 12168954.
  • Vuorela P, Ala-Mello S, Saloranta C, Penttinen M, Pöyhönen M, Huoponen K, Borozdin W, Bausch B, Botzenhart EM, Wilhelm C, Kääriäinen H, Kohlhase J (Oct 2007). "Molecular analysis of the CHD7 gene in CHARGE syndrome: identification of 22 novel mutations and evidence for a low contribution of large CHD7 deletions". Genetics in Medicine. 9 (10): 690–4. doi:10.1097/GIM.0b013e318156e68e. PMID 18073582.
  • Layman WS, McEwen DP, Beyer LA, Lalani SR, Fernbach SD, Oh E, Swaroop A, Hegg CC, Raphael Y, Martens JR, Martin DM (Jun 2009). "Defects in neural stem cell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndrome". Human Molecular Genetics. 18 (11): 1909–23. doi:10.1093/hmg/ddp112. PMC 2678924. PMID 19279158.
  • Buck, Cassandra; Balasubramanian, Ravikumar; Crowley, Jr, William F (2013-07-18). Isolated Gonadotropin-Releasing Hormone (GnRH) Deficiency. University of Washington, Seattle. PMID 20301509. NBK1334. In Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (1993). Pagon RA, Bird TD, Dolan CR (eds.). GeneReviews. Seattle WA: University of Washington, Seattle. PMID 20301295.
  • Lalani SR, Hefner MA, Belmont JW, Davenport SL (2012-02-02). "CHD7 Disorder". CHARGE Syndrome. University of Washington, Seattle. PMID 20301296. NBK1117. In GeneReviews
  • Bardakjian T, Weiss A, Schneider AS (2006-05-26). "Microphthalmia/Anophthalmia/Coloboma Spectrum – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY". Anophthalmia/Microphthalmia Overview. University of Washington, Seattle. PMID 20301552. NBK1378. In GeneReviews

External links

  • v
  • t
  • e
  • 2ckc: SOLUTION STRUCTURES OF THE BRK DOMAINS OF THE HUMAN CHROMO HELICASE DOMAIN 7 AND 8, REVEALS STRUCTURAL SIMILARITY WITH GYF DOMAIN SUGGESTING A ROLE IN PROTEIN INTERACTION
    2ckc: SOLUTION STRUCTURES OF THE BRK DOMAINS OF THE HUMAN CHROMO HELICASE DOMAIN 7 AND 8, REVEALS STRUCTURAL SIMILARITY WITH GYF DOMAIN SUGGESTING A ROLE IN PROTEIN INTERACTION
  • 2v0f: BRK DOMAIN FROM HUMAN CHD7
    2v0f: BRK DOMAIN FROM HUMAN CHD7
  • 2v0e: BRK DOMAIN FROM HUMAN CHD7
    2v0e: BRK DOMAIN FROM HUMAN CHD7
  • v
  • t
  • e
3.6.1
3.6.2
3.6.3-4: ATPase
3.6.3
Cu++ (3.6.3.4)
Ca+ (3.6.3.8)
Na+/K+ (3.6.3.9)
H+/K+ (3.6.3.10)
  • ATP4A
Other P-type ATPase
3.6.4
3.6.5: GTPase
3.6.5.1: Heterotrimeric G protein
3.6.5.2: Small GTPase > Ras superfamily
3.6.5.3: Protein-synthesizing GTPase
3.6.5.5-6: Polymerization motors
  • v
  • t
  • e
Transcription (Bacterial, Eukaryotic)
Transcriptional regulation
prokaryotic
eukaryotic
Histone-modifying enzymes
(histone/nucleosome):
DNA methylation:
Chromatin remodeling:
  • CHD7
both
Promotion
Initiation
Elongation
Termination
(bacterial,
eukaryotic)